异动盘点1209 | 内房股、有色股集体下跌；Wave Life Sciences涨147.26%创年内新高

Group 1 - Bai'ao Saitou-B (02315) rose over 9.4% after announcing its RMB ordinary shares will be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 10, 2025 [1] - "First Chinese Noodle Restaurant Stock" Yujian Xiaomian (02408) increased by 4.69% as the chairman announced plans to open its first store in Singapore by the end of the month, marking a step towards internationalization [1] - Chinese property stocks collectively declined, with China Overseas Hong Kong Group (00081) down 9.38%, Greentown China (03900) down 4.66%, New World Development (01030) down 3.24%, and Sunac China (01918) down 1.55% [1] Group 2 - Haichang Ocean Park (02255) fell by 9% amid ongoing issues related to the "Xiangyuan System" where several income rights products have not been redeemed [1] - Non-ferrous metal stocks saw significant declines, with Jiangxi Copper (00358) down 6.24%, Luoyang Molybdenum (03993) down 6.48%, China Aluminum (02600) down 5.43%, and Zijin Mining (02899) down 4.24% due to expectations of interest rate adjustments by the Bank of Japan and hawkish comments from European Central Bank officials [2] - Kangnai Optical (02276) dropped over 1.32% as Google announced it is developing two types of AI glasses to compete with Meta's products [2] Group 3 - Zhaoyan New Drug (06127) surged over 7.76% as reports indicated that the price of crab-eating monkeys has exceeded 100,000 yuan [2] - Kingsoft Cloud (03896) rose over 1.78% following a Goldman Sachs report highlighting Xiaomi's exploration of large language models for various applications [2] - Cornerstone Pharmaceuticals-B (02616) increased by over 0.5% after announcing that its drug has been included in the latest National Medical Insurance Drug List, effective January 1, 2026 [3] Group 4 - Marvell Technology (MRVL.US) fell 6.99% as reports indicated Microsoft is negotiating with Broadcom for future custom chip designs, potentially shifting away from Marvell [4] - GCL Global (GCL.US) rose 1.74% after announcing a $3 million strategic investment from ADATA [4] - Kymera Therapeutics (KYMR.US) surged 41.55% to a record high following positive trial results for its drug KT-621 [4] Group 5 - Wave Life Sciences (WVE.US) skyrocketed 147.26% to a yearly high after reporting positive mid-term results for its obesity treatment WVE-007 [5] - Warner Bros. Discovery (WBD.US) rose 4.41% amid speculation that Paramount is considering a higher acquisition offer for the company [5] - Carvana (CVNA.US) increased by 12.06% after being announced for inclusion in the S&P 500 index, effective December 22 [5]